Compare drug alternatives
Vyepti® Alternatives
Vyepti®
(eptinezumab-jjmr)
Vyepti
-
Migraine
- Emgality®
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Vypeti is a prescription medication used for migraine prevention. It is administered as an intravenous infusion four times a year. The most common reported side effects were stuffy nose and scratchy throat.
Vyepti is FDA approved for the following indications: Migraine prevention.
Qulipta®
(Atogepant)
Qulipta
-
Migraine
- Emgality®
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Ubrelvy®
Prescription Only
Qulipta is a prescription medication that is used as a preventative treatment for episodic migraines. It is a tablet that is taken once daily. The most common side effects are fatigue, nausea, and constipation.
Qulipta is FDA approved for the following indications: Migraine prevention.
Dosage & Administration
Administration
Intravenous infusion (must be diluted)
Oral
Dosing
100 mg every 3 months or 300 mg (for some patients)
10 mg, 30 mg, or 60 mg once daily. Severe Renal Impairment or End-Stage Renal Disease: 10 mg once daily.
Latin Shorthand
100 mg q3mo
10mg qd, 30mg qd or 60mg qd
Renal Impairment: 10mg qd
Financial Assistance
Copay
$0
$0
Annual Cap
$200 per infusion for administration costs
$6,000
Assistance Expiration
Calendar year
12 30-day prescription fills
Generics
No lower-cost generic available
No lower-cost generic available